Literature DB >> 3584350

Gas chromatographic analysis of metabolites of the cell differentiating agent hexamethylene bisacetamide.

M J Egorin, E G Zuhowski, M S Nayar, P S Callery.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3584350     DOI： 10.1016/s0378-4347(00)83203-x

Source DB:  PubMed          Journal:  J Chromatogr


× No keyword cloud information.
  4 in total

1.  The effect of the monoamine oxidase inhibitor isocarboxazid on the canine metabolism of the cell-differentiating agent hexamethylene bisacetamide.

Authors:  B A Conley; G F Sewack; M J Egorin; B Subramanyam; J G Page; C K Grieshaber
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

2.  Approaches to optimal dosing of hexamethylene bisacetamide.

Authors:  B A Conley; M J Egorin; V Sinibaldi; G Sewack; C Kloc; L Roberts; E G Zuhowski; A Forrest; D A Van Echo
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

3.  Biological monitoring of isocyanates and related amines. I. Determination of 1,6-hexamethylene diamine (HDA) in hydrolysed human urine after oral administration of HDA.

Authors:  T Brorson; G Skarping; J F Sandström; M Stenberg
Journal:  Int Arch Occup Environ Health       Date:  1990       Impact factor: 3.015

4.  Salivary concentrations of hexamethylene bisacetamide (HMBA) in patients receiving 5-day continuous infusions.

Authors:  B A Conley; M J Egorin; E G Zuhowski; V J Sinibaldi; D E Peterson
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.